International Stem Cell Corporation

International Stem Cell Corporation financial statements

International Stem Cell Corporation's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 9.1M10-K
Net income−USD 418K10-K
Cash and equivalentsUSD 793K10-Q

International Stem Cell Corporation financials on 6ix · International Stem Cell Corporation on 6ix